BNP Paribas upgraded shares of Axalta Coating Systems (NYSE:AXTA – Free Report) from a neutral rating to an outperform rating in a research report report published on Thursday, Marketbeat Ratings reports. They currently have $38.00 target price on the specialty chemicals company’s stock.
Several other equities analysts have also recently issued reports on the stock. Wolfe Research raised shares of Axalta Coating Systems from a “peer perform” rating to an “outperform” rating and set a $41.00 price objective on the stock in a research note on Friday, January 17th.
Deutsche Bank Aktiengesellschaft decreased their target price on Axalta Coating Systems from $44.00 to $42.00 and set a “buy” rating on the stock in a report on Thursday, December 19th.
Mizuho decreased their price target on Axalta Coating Systems from $43.00 to $41.00 and set an “outperform” rating for the company in a research report on Tuesday, January 7th.
Barclays boosted their price target on shares of Axalta Coating Systems from $44.00 to $45.00 and gave the company an “overweight” rating in a report on Wednesday, February 5th.
Finally, Wells Fargo & Company reduced their price objective on Axalta Coating Systems from $42.00 to $37.00 and set an “overweight” rating for the company in a research note on Wednesday.
Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Axalta Coating Systems presently has an average rating of “Moderate Buy” and an average price target of $41.64.
Read Our Latest Analysis on AXTAAxalta Coating Systems Stock PerformanceAXTA stock opened at $30.64 on Thursday. Axalta Coating Systems has a fifty-two week low of $27.
70 and a fifty-two week high of $41.66. The company has a market capitalization of $6.
68 billion, a P/E ratio of 17.21, a PEG ratio of 0.92 and a beta of 1.
33. The company has a 50-day simple moving average of $34.48 and a 200 day simple moving average of $36.
17. The company has a quick ratio of 1.47, a current ratio of 2.
01 and a debt-to-equity ratio of 1.74. Axalta Coating Systems (NYSE:AXTA – Get Free Report) last released its earnings results on Tuesday, February 4th.
The specialty chemicals company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.
09. Axalta Coating Systems had a return on equity of 26.29% and a net margin of 7.
41%. The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.
31 billion. During the same period in the prior year, the firm posted $0.43 earnings per share.
The firm’s revenue for the quarter was up 1.1% compared to the same quarter last year. Sell-side analysts predict that Axalta Coating Systems will post 2.
55 earnings per share for the current fiscal year. Insider Buying and Selling at Axalta Coating SystemsIn other news, insider Troy D. Weaver sold 10,457 shares of the business’s stock in a transaction dated Monday, February 10th.
The shares were sold at an average price of $37.57, for a total transaction of $392,869.49.
Following the transaction, the insider now owns 74,905 shares in the company, valued at approximately $2,814,180.85. The trade was a 12.
25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.
40% of the company’s stock. Hedge Funds Weigh In On Axalta Coating SystemsSeveral institutional investors and hedge funds have recently added to or reduced their stakes in the company. Eagle Bay Advisors LLC grew its holdings in shares of Axalta Coating Systems by 116.
3% during the 4th quarter. Eagle Bay Advisors LLC now owns 824 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 443 shares in the last quarter. Financial Management Professionals Inc.
boosted its stake in Axalta Coating Systems by 11,757.1% during the first quarter. Financial Management Professionals Inc.
now owns 830 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 823 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in Axalta Coating Systems by 60.7% in the 4th quarter.
Jones Financial Companies Lllp now owns 1,318 shares of the specialty chemicals company’s stock valued at $45,000 after buying an additional 498 shares during the period. UMB Bank n.a.
raised its stake in shares of Axalta Coating Systems by 35.4% in the 4th quarter. UMB Bank n.
a. now owns 2,093 shares of the specialty chemicals company’s stock valued at $72,000 after buying an additional 547 shares in the last quarter. Finally, Plato Investment Management Ltd lifted its holdings in shares of Axalta Coating Systems by 156.
4% during the 4th quarter. Plato Investment Management Ltd now owns 2,238 shares of the specialty chemicals company’s stock worth $77,000 after acquiring an additional 1,365 shares during the period. 98.
28% of the stock is currently owned by institutional investors. About Axalta Coating Systems (Get Free Report)Axalta Coating Systems Ltd., through its subsidiaries, manufactures, markets, and distributes high-performance coatings systems in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
The company operates through two segments, Performance Coatings and Mobility Coatings.Featured ArticlesFive stocks we like better than Axalta Coating SystemsManufacturing Stocks InvestingRobinhood Strategies Could Be a Game-Changer for Young InvestorsWhy is the Ex-Dividend Date Significant to Investors?Are These 3 Retail Stocks Oversold or Really in Trouble?Are Penny Stocks a Good Fit for Your Portfolio?IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead.
Business
Axalta Coating Systems (NYSE:AXTA) Upgraded at BNP Paribas

BNP Paribas upgraded shares of Axalta Coating Systems (NYSE:AXTA – Free Report) from a neutral rating to an outperform rating in a research report report published on Thursday, Marketbeat Ratings reports. They currently have $38.00 target price on the specialty chemicals company’s stock. Several other equities analysts have also recently issued reports on the stock. [...]